Paraguay announces retatrutida, but agency claims there is no authorization; drug is still in clinical study phase
A Paraguayan lab announced a drug for obesity treatment which lacks regulatory approval, as it is still in clinical trials despite promotional events.
Know the risks of retatrutida, a weight loss pen still in study phase
The article discusses the risks associated with the use of retatrutida, a weight loss pen not yet approved for use in any country and currently under clinical study.